Electromed, Inc. (ELMD) Current Ratio
- Current ratio · latest quarter: Value 4.69×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.69× | Current assets / current liabilities. $57.37M ÷ $12.22M ≈ 4.69× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 57.37M USD | Assets, Current |
| Current obligations | 12.22M USD | Liabilities, Current |
| Cash and equivalents | 20.45M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 29.80M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 3.68M USD | Inventory, Net |
| Payables | 2.64M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $57.37M | $12.22M | $20.45M | (m) | $29.80M | $3.68M | $2.64M | (m) | 4.69× |
| 2026-03-31 | $50.23M | $10.23M | $16.98M | (m) | $28.25M | $3.29M | $2.60M | (m) | 4.91× |
| 2025-12-31 | $45.57M | $9.38M | $13.79M | (m) | $26.26M | $3.46M | $2.32M | (m) | 4.86× |
| 2025-09-30 | $44.56M | $8.76M | $14.11M | (m) | $24.76M | $3.77M | $3.14M | (m) | 5.09× |
| 2025-06-30 | $45.08M | $10.47M | $15.29M | (m) | $24.66M | $3.30M | $2.67M | (m) | 4.31× |
| 2025-03-31 | $44.20M | $8.51M | $15.24M | (m) | $23.44M | $2.97M | $1.88M | (m) | 5.19× |
| 2024-12-31 | $44.19M | $8.67M | $16.23M | (m) | $22.77M | $3.08M | $1.51M | (m) | 5.10× |
| 2024-09-30 | $41.01M | $7.42M | $13.86M | (m) | $22.37M | $3.43M | $1.78M | (m) | 5.53× |
| 2024-06-30 | $44.17M | $7.68M | $16.08M | (m) | $23.33M | $3.71M | $1.01M | (m) | 5.75× |
| 2024-03-31 | $41.32M | $6.33M | $11.71M | (m) | $23.91M | $4.18M | $792.00K | (m) | 6.53× |
| 2023-12-31 | $39.27M | $6.57M | $10.43M | (m) | $22.99M | $4.76M | $1.04M | (m) | 5.97× |
| 2023-09-30 | $36.20M | $5.78M | $7.02M | (m) | $23.45M | $4.48M | $1.06M | (m) | 6.27× |
| 2023-06-30 | $37.79M | $8.05M | $7.37M | (m) | $24.13M | $4.22M | $1.37M | (m) | 4.69× |
| 2023-03-31 | $35.17M | $6.42M | $6.78M | (m) | $22.34M | $3.45M | $1.29M | (m) | 5.48× |
| 2022-12-31 | $34.16M | $6.01M | $6.91M | (m) | $21.55M | $3.47M | $785.00K | (m) | 5.68× |
| 2022-09-30 | $33.22M | $5.95M | $6.00M | (m) | $20.96M | $3.67M | $1.26M | (m) | 5.58× |
| 2022-06-30 | $34.54M | $7.15M | $8.15M | (m) | $21.05M | $3.18M | $1.26M | (m) | 4.83× |
| 2022-03-31 | $32.99M | $4.97M | $9.84M | (m) | $19.61M | $2.09M | $1.16M | (m) | 6.64× |
| 2021-12-31 | $32.45M | $4.67M | (m) | (m) | $19.11M | $1.79M | $1.29M | $51.00K | 6.95× |
| 2021-09-30 | $32.43M | $4.81M | (m) | (m) | $18.36M | $2.02M | $1.26M | $69.00K | 6.74× |
| 2021-06-30 | $31.70M | $4.64M | $11.89M | (m) | $17.03M | $2.11M | $685.00K | (m) | 6.83× |
| 2021-03-31 | $32.29M | $4.24M | (m) | (m) | $16.24M | $2.26M | $1.02M | $40.68K | 7.62× |
| 2020-12-31 | $30.90M | $3.49M | (m) | (m) | $15.40M | $2.60M | $722.90K | $40.45K | 8.86× |
| 2020-09-30 | $29.34M | $3.53M | (m) | (m) | $13.62M | $3.07M | $766.20K | $55.32K | 8.31× |
| 2020-06-30 | $28.02M | $2.99M | $10.48M | (m) | $12.94M | $3.08M | $556.00K | $72.00K | 9.38× |
| 2020-03-31 | $27.79M | $3.62M | (m) | (m) | $13.29M | $2.65M | $874.13K | $76.87K | 7.67× |
| 2019-12-31 | $26.29M | $2.99M | (m) | (m) | $12.72M | $2.65M | $610.61K | $82.94K | 8.78× |
| 2019-09-30 | $25.03M | $3.28M | (m) | (m) | $12.72M | $2.75M | $1.05M | $82.70K | 7.64× |
| 2019-06-30 | $24.54M | $3.65M | (m) | (m) | $12.76M | $2.62M | $586.58K | $30.32K | 6.72× |
| 2019-03-31 | $24.00M | $3.24M | (m) | (m) | $12.28M | $2.71M | $622.43K | (m) | 7.41× |
| 2018-12-31 | $23.02M | $3.07M | (m) | (m) | $11.94M | $2.74M | $713.10K | (m) | 7.50× |
| 2018-09-30 | $23.38M | $4.48M | (m) | (m) | $11.55M | $2.84M | $850.48K | $1.09M | 5.22× |
| 2018-06-30 | $23.29M | $4.80M | (m) | (m) | $11.81M | $2.49M | $810.64K | $1.10M | 4.85× |
| 2018-03-31 | $19.92M | $3.75M | (m) | (m) | $10.08M | $2.21M | $614.87K | $1.11M | 5.32× |
| 2017-12-31 | $19.29M | $3.78M | (m) | (m) | $9.68M | $2.39M | $704.11K | $1.12M | 5.11× |
| 2017-09-30 | $18.68M | $2.74M | (m) | (m) | $9.64M | $2.45M | $678.93K | $51.21K | 6.81× |
| 2017-06-30 | $18.48M | $2.90M | (m) | (m) | $9.95M | $2.56M | $663.38K | $50.70K | 6.38× |
| 2017-03-31 | $17.41M | $2.77M | (m) | (m) | $8.93M | $2.59M | $593.81K | $50.20K | 6.28× |
| 2016-12-31 | $16.11M | $2.36M | (m) | (m) | $8.28M | $2.57M | $466.86K | $49.72K | 6.83× |
| 2016-09-30 | $15.11M | $1.91M | (m) | (m) | $8.04M | $2.61M | $425.01K | $44.96K | 7.91× |
| 2016-06-30 | $15.83M | $3.07M | (m) | (m) | $7.61M | $2.48M | $589.23K | $46.31K | 5.15× |
| 2016-03-31 | $15.19M | $2.89M | (m) | (m) | $7.31M | $2.33M | $668.80K | $47.63K | 5.26× |
| 2015-12-31 | $14.17M | $2.43M | (m) | (m) | $6.90M | $2.39M | $620.92K | $48.77K | 5.83× |
| 2015-09-30 | $12.90M | $2.13M | $3.78M | (m) | $6.46M | $2.16M | $522.01K | $49.41K | 6.05× |
| 2015-06-30 | $12.59M | $2.28M | (m) | (m) | $6.52M | $2.07M | $538.52K | $48.75K | 5.52× |
| 2015-03-31 | $12.18M | $2.14M | $2.90M | (m) | $6.39M | $2.40M | $684.29K | $48.10K | 5.70× |
| 2014-12-31 | $11.69M | $1.89M | $2.45M | (m) | $6.63M | $2.23M | $480.99K | $47.13K | 6.17× |
| 2014-09-30 | $11.37M | $2.16M | $2.28M | (m) | $6.36M | $2.24M | $781.82K | $47.00K | 5.26× |
| 2014-06-30 | $10.62M | $1.82M | $1.50M | (m) | $6.49M | $2.24M | $380.58K | $46.38K | 5.84× |
| 2014-03-31 | $10.77M | $2.41M | $772.43K | (m) | $6.47M | $2.55M | $1.00M | $45.76K | 4.47× |
| 2013-12-31 | $12.27M | $2.60M | $1.24M | (m) | $7.04M | $2.27M | $1.30M | $45.16K | 4.71× |
| 2013-09-30 | $12.30M | $2.36M | $1.08M | (m) | $7.99M | $1.43M | $950.15K | $52.66K | 5.21× |
| 2013-06-30 | $12.42M | $2.19M | $503.56K | (m) | $9.01M | $1.38M | $643.68K | $57.54K | 5.66× |
| 2013-03-31 | $13.81M | $4.25M | $504.95K | (m) | $9.20M | $2.14M | $835.72K | $1.39M | 3.25× |
| 2012-12-31 | $14.25M | $2.82M | $1.01M | (m) | $9.73M | $1.90M | $753.10K | $66.19K | 5.05× |
| 2012-09-30 | $15.73M | $3.74M | $1.48M | (m) | $10.42M | $2.31M | $554.09K | $159.87K | 4.21× |
| 2012-06-30 | $16.30M | $4.17M | $1.70M | (m) | $10.85M | $2.39M | $749.99K | $254.02K | 3.91× |
| 2012-03-31 | $16.13M | $4.03M | $1.39M | (m) | $11.09M | $2.41M | $724.50K | $351.48K | 4.00× |
| 2011-12-31 | $16.04M | $4.07M | $1.75M | (m) | $10.70M | $2.40M | $623.37K | $437.30K | 3.94× |
| 2011-09-30 | $16.65M | $4.49M | $2.95M | (m) | $10.40M | $2.16M | $758.99K | $403.75K | 3.71× |
| 2011-06-30 | $16.63M | $4.41M | $4.09M | (m) | $9.59M | $1.86M | $733.62K | $438.27K | 3.77× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |